Who owns Ngm Biopharmaceuticals Inc?
- Ticker: NGM
- CUSIP Number: 62921n105
Tip: Access positions for across all investors
Analyze quarterly positions in Ngm Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Ngm Biopharmaceuticals stock
Who bought or sold Ngm Biopharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Column Group | 18M | $16M | 0% | Dec 2023 |
|
Vanguard Group | 2.8M | $2.4M | 0% | Dec 2023 |
|
EcoR1 Capital | 2.4M | $2.0M | -63% | Dec 2023 |
|
Millennium Management | 1.3M | $1.1M | 498% | Dec 2023 |
|
Euclidean Capital | 992k | $852k | 0% | Dec 2023 |
|
Two Sigma Advisers | 587k | $504k | 24% | Dec 2023 |
|
Jacobs Levy Equity Management | 556k | $478k | 0% | Dec 2023 |
|
Two Sigma Investments | 491k | $421k | 21% | Dec 2023 |
|
Federated Investors | 345k | $297k | -41% | Dec 2023 |
|
GSA Capital Partners | 335k | $287k | 57% | Dec 2023 |
|
D. E. Shaw & Co | 308k | $265k | -4% | Dec 2023 |
|
Charles Schwab Investment Management | 279k | $239k | 1% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 221k | $190k | 155% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 213k | $183k | 100% | Dec 2023 |
|
Squarepoint Ops | 213k | $183k | 52% | Dec 2023 |
|
Exchange Traded Concepts | 186k | $296k | 74% | Mar 2024 |
|
Dimensional Fund Advisors | 155k | $133k | -26% | Dec 2023 |
|
Bank of New York Mellon | 133k | $212k | -4% | Mar 2024 |
|
Man Group | 120k | $103k | -26% | Dec 2023 |
|
Goldman Sachs Group | 111k | $95k | -60% | Dec 2023 |
|
Barclays | 91k | $78k | 135% | Dec 2023 |
|
Citadel Advisors | 73k | $62k | -56% | Dec 2023 |
|
Hennion & Walsh Asset Management | 71k | $112k | 7% | Mar 2024 |
|
State of Wisconsin Investment Board | 69k | $59k | -41% | Dec 2023 |
|
Rhumbline Advisers | 65k | $56k | 0% | Dec 2023 |
|
Alliancebernstein | 64k | $55k | -6% | Dec 2023 |
|
Mackenzie Financial | 63k | $54k | 40% | Dec 2023 |
|
Jane Street | 59k | $51k | -17% | Dec 2023 |
|
Bank of America Corporation | 57k | $49k | -49% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 49k | $42k | 0% | Dec 2023 |
|
Ohio Pers | 48k | $42k | 0% | Dec 2023 |
|
UBS Group | 47k | $41k | 111% | Dec 2023 |
|
Russell Investments | 44k | $38k | -65% | Dec 2023 |
|
Jpmorgan Chase & Co | 28k | $24k | -98% | Dec 2023 |
|
Clarius | 27k | $43k | 1% | Mar 2024 |
|
Tudor Investment Corporation | 25k | $22k | 0% | Dec 2023 |
|
SG Americas Securities | 24k | $20k | 8% | Dec 2023 |
|
Carson Advisory | 23k | $19k | 42% | Dec 2023 |
|
American International | 22k | $19k | 0% | Dec 2023 |
|
Jasper Ridge Partners | 19k | $17k | -94% | Dec 2023 |
|
Principal Financial Group | 19k | $16k | -8% | Dec 2023 |
|
Wells Fargo & Company | 14k | $12k | 24% | Dec 2023 |
|
Royal Bank of Canada | 13k | $11k | 40% | Dec 2023 |
|
Hrt Financial | 13k | $11k | 100% | Dec 2023 |
|
Us Bancorp | 13k | $11k | 100% | Dec 2023 |
|
Walleye Trading Advisors | 12k | $11k | -92% | Dec 2023 |
|
Florida State Board of Administration | 11k | $9.7k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 10k | $9.0k | 0% | Dec 2023 |
|
T. Rowe Price Associates | 10k | $9.0k | -77% | Dec 2023 |
|
Citigroup | 7.4k | $6.3k | 600% | Dec 2023 |
|
Cutler | 3.4k | $4.4k | 10% | Mar 2024 |
|
Summit Investment Advisors | 3.1k | $2.7k | 0% | Dec 2023 |
|
Legal & General Group | 3.0k | $2.6k | 0% | Dec 2023 |
|
Amalgamated Bank | 1.4k | $2.0k | -63% | Mar 2024 |
|
Capital Advisors | 777.00 | $999.999000 | 100% | Mar 2024 |
|
GAMMA Investing | 346.00 | $550.001600 | 0% | Mar 2024 |
|
NISA Investment Advisors | 75.00 | $63.997500 | -93% | Dec 2023 |
|
Covestor | 65.00 | $0 | 261% | Dec 2023 |
|
Simplex Trading | 28.00 | $0 | -81% | Mar 2024 |
|
CWM | 6.00 | $0 | -99% | Mar 2024 |
|
Who sold out of Ngm Biopharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Boxer Capital | Sep 2023 | 500k | $535k |
Parkwood | Sep 2023 | 68k | $73k |
CornerCap Investment Counsel | Sep 2023 | 51k | $55k |
Algert Coldiron Investors | Sep 2023 | 37k | $40k |
Cubist Systematic Strategies | Sep 2023 | 34k | $37k |
Point72 Middle East FZE | Sep 2023 | 29k | $31k |
Raymond James & Associates | Dec 2023 | 21k | $18k |
Franklin Resources | Sep 2023 | 14k | $15k |
Virtu Financial | Sep 2023 | 11k | $12k |
Steward Partners Investment Advisory | Sep 2023 | 4.1k | $4.4k |
China Universal Asset Management | Sep 2023 | 2.1k | $2.0k |
Pnc Financial Services | Sep 2023 | 512.00 | $547.993600 |
Daiwa Securities Group | Sep 2023 | 265.00 | $0 |
Glassman Wealth Services | Sep 2023 | 92.00 | $97.998400 |